Media statement
London, 9th July 2021
If you are covering the reclassification of the progestogen-only pill, you may find the following statement from MSI Reproductive Choices UK helpful.
Simphiwe Sesane contraceptive nurse and faculty registered trainer at MSI Reproductive Choices said:
“The reclassification of the progestogen-only pill, which can now be sold directly by a pharmacist without a prescription, is a great step forward. It will improve access and provide anyone seeking an extremely safe method of contraception more choice over how and where they access it. All too often our teams speak to people who have become pregnant while on contraception waiting lists and these challenges have only been exacerbated by the global pandemic, so this initiative is especially welcome in that context.
“However, while this reclassification is a positive move, cost will be a barrier for some. Progestogen-only contraception will continue to be available at no cost from GPs and sexual and reproductive health services, but ultimately we would like to see it available for free through NHS community pharmacies too.”
For further information please contact:
Email: [email protected]
Telephone: +44 (0) 7769 166 516
